Plasma cell differentiation requires silencing of B cell transcription, while it establishes antibody-secretory function and long-term survival. The transcription factors Blimp-1 and IRF4 are essential for the generation of plasma cells; however, their function in mature plasma cells has remained elusive. We found that while IRF4 was essential for the survival of plasma cells, Blimp-1 was dispensable for this. Blimp-1-deficient plasma cells retained their transcriptional identity but lost the ability to secrete antibody. Blimp-1 regulated many components of the unfolded protein response (UPR), including XBP-1 and ATF6. The overlap in the functions of Blimp-1 and XBP-1 was restricted to that response, with Blimp-1 uniquely regulating activity of the kinase mTOR and the size of plasma cells. Thus, Blimp-1 was required for the unique physiological ability of plasma cells that enables the secretion of protective antibody.
The production of antibodies is an essential arm of the immune response that provides both immediate protection against a current infection and long-term immunity to re-exposure to the same pathogen. The antibody-secreting cell compartment consists of short-lived proliferating plasmablasts (PBs), which are generated early in an immune response, and long-lived post-mitotic plasma cells (PCs), which reside in specialized niches in the bone marrow (BM) 1, 2 . These long-lived PCs have been shown to maintain high titers of protective antibody for decades after exposure to pathogen or immunization 3 . Thus, understanding the factors that control the production, function and long-term survival of PCs is critical for both improved vaccine design and the development of novel approaches for targeting pathogenic PCs in diseases such as multiple myeloma and systemic lupus erythematosus.
To achieve the dual goals of maintaining an extremely high rate of immunoglobulin secretion while ensuring their own long-term survival, PCs show a highly specialized morphology with an enlarged cytoplasm and a tightly arranged endoplasmic reticulum (ER). PCs also constitutively activate the unfolded protein response (UPR), a specialized sensing mechanism for detecting and dealing with large amounts of protein that pass through the ER 4 .
The differentiation of activated B cells into PCs requires coordinated changes in the expression of many hundreds of genes, including the silencing of B cell-associated transcripts, such as those encoding the transcription factors Pax5, Bach2 and Bcl-6, and the activation of a suite of PC-specific genes 5, 6 . This developmental program is guided by the following triad of transcription factors: IRF4 (encoded by Irf4), Blimp-1 (encoded by Prdm1) and XBP-1 (encoded by Xbp1). IRF4 not only has high expression in PCs but also is essential for PC development, at least in part due to its regulation of Prdm1 (refs. [7] [8] [9] . Blimp-1 is expressed in all antibody-secreting cells and is also required for their differentiation beyond an early point [10] [11] [12] . Blimp-1 has so far been thought of as a transcriptional repressor that silences several important B cell genes, including Pax5 (ref. 13) , Myc 14 , Ciita 15 , Bcl6, Spib and Id3 (ref. 16 ), although there is only limited understanding of its targets in PCs 17 . XBP-1, an important component of the UPR, was initially proposed to be essential for PC formation 18 ; however, subsequent evidence has suggested that XBP-1 is required more specifically for immunoglobulin production [19] [20] [21] [22] . As a consequence of the important functions of IRF4 and Blimp-1 early in the differentiation process, there is little current knowledge about the function of these factors in long-lived PCs 23, 24 . Here we used a genetic approach to investigate the functional consequences of the loss of IRF4, Blimp-1 or XBP-1 in mature post-mitotic BM PCs.
RESULTS

Inactivation of IRF4 and Blimp-1 in PCs
To assess the importance of IRF4 and Blimp-1 in mature BM PCs, we crossed mice carrying loxP-flanked alleles encoding either transcription factor (Irf4 fl/fl or Prdm1 fl/fl ) 25, 26 with Rosa26-Cre ERT2 mice (which have tamoxifen-inducible expression of Cre recombinase from the ubiquitous Rosa26 locus) 27 . This system allowed tamoxifen-inducible Figure 1 Inactivation of Irf4 and Prdm1 in PCs. (a) Frequency of Irf4 fl/+ Cre ERT2 (Irf4 fl/+ ) or Irf4 fl/− Cre ERT2 (Irf4 fl/− ) PCs, identified as CD138 + B220 lo GFP + (left), or Prdm1 +/gfp Cre ERT2 (Prdm1 +/gfp ) or Prdm1 fl/gfp Cre ERT2 (Prdm1 fl/gfp ) PCs, identified as CD138 + Blimp-1-GFP + (right), among total BM cells from Rag1 −/− host mice given B cells of the those genotypes, assessed at various times (horizontal axes) after treatment of host mice with tamoxifen to induce inactivation of Irf4 (reported by GFP expression) or Prdm1 (experimental plan, Supplementary Fig. 1a ). (b) Frequency of BM PCs from Prdm1 +/gfp Cre ERT2 or Prdm1 fl/gfp Cre ERT2 mice various days (horizontal axis) after treatment with tamoxifen (experimental plan, Supplementary Fig. 1b ). Each symbol (a,b) represents an individual mouse; small horizontal lines indicate the mean. *P < 0.05 and **P < 0.005 (paired t-test). Data are pooled from three experiments.
inactivation of Irf4 or Prdm1 in pre-existing PCs. To facilitate the tracking of PCs, Prdm1 fl/fl and Prdm1 +/+ control mice also carried a Prdm1 gfp reporter allele that expresses green fluorescent protein (GFP) but no functional Blimp-1 (Prdm1 fl/gfp Cre ERT2 or Prdm1 +/gfp Cre ERT2 ) 11 , while Irf4 fl/fl mice carried an internal GFP-encoding cassette that reports gene inactivation 26 . We transferred B cells from those mice into B cell-and T cell-deficient Rag1 −/− mice to generate a large population of PCs and induced Cre activity by administration of tamoxifen to the host mice 14 d later. Although inactivation of Irf4 occurred equivalently in Irf4 fl/+ Cre ERT2 and Irf4 fl/− Cre ERT2 B cells (approximately 15% GFP + cells for each genotype; data not shown), GFP + PCs were lost from the BM as early as 2 d after treatment with tamoxifen ( Fig. 1a and Supplementary Fig. 1a ), which demonstrated that IRF4 was indispensable for PC survival. In contrast, inactivation of Prdm1 by an identical strategy resulted in a PC population was that stable for many weeks after treatment with tamoxifen ( Fig. 1a and Supplementary Fig. 1a ). To confirm that result, we induced inactivation of Prdm1 in naive Prdm1 fl/gfp Cre ERT2 mice and again found that BM PCs persisted without Blimp-1 ( Fig. 1b and Supplementary Fig. 1b) . We observed a similar difference in the dependence of PC survival on IRF4 and Blimp-1 in the spleen (Supplementary Fig. 1a-d) .
Although both models showed a significant reduction in PC numbers at the latest time points after inactivation of Prdm1, the data derived from the two genotypes were not strictly comparable, as the Prdm1 +/gfp B cells continued to produce new PCs throughout the course of the experiment, while the Prdm1 fl/gfp cells lacked this capacity ( Fig.  1a,b and Supplementary Fig. 1c ). Consistent with that conclusion, we observed no significant change in the proportion of spleen or BM cells in tamoxifen-treated Prdm1 fl/gfp mice that displayed a PC phenotype, either at steady state or after immunization with a protein antigen in alum, over the time frame examined (Fig. 1a,b and Supplementary Fig. 1c-e ). We assessed the efficiency of the ablation of Prdm1 by transferring Prdm1 fl/gfp Cre ERT2 or Prdm1 +/gfp Cre ERT2 B cells into Rag1 −/− host mice and treating the recipients with tamoxifen 2 d after transfer, before PCs could be formed. This approach completely blocked PC differentiation ( Supplementary  Figs. 1f and 2a) , which mimicked the conditional removal of Prdm1 from activated B cells in vitro 12, 28 . PCR genotyping of purified B cells and PCs confirmed efficient inactivation of the Prdm1 locus in both cell types ( Supplementary Fig. 2b) . These data demonstrated that Blimp-1 was not essential for the long-term survival of BM PCs.
Blimp-1-regulated genes in PCs
The long-term persistence of Blimp-1-deficient PCs enabled us to investigate the effect of the loss of Blimp-1 on the transcriptome of long-lived PCs. We sequenced RNA from BM PCs purified from Prdm1 fl/gfp Cre ERT2 and Prdm1 +/gfp Cre ERT2 mice 21 d after treating the mice with tamoxifen. Analysis of the frequency of Prdm1 transcripts spanning exons 5-6, which are removed by Cre-mediated excision of the loxP-flanked exon 5, revealed an 87% reduction in frequency of full-length transcripts in Prdm1 fl/gfp Cre ERT2 cells, compared with their abundance in Prdm1 +/gfp Cre ERT2 cells ( Supplementary  Fig. 2c ). 465 genes were expressed differentially in Blimp-1-deficient (Prdm1 fl/gfp Cre ERT2 ) PCs relative to their expression in control (Prdm1 +/gfp Cre ERT2 ) PCs ( Fig. 2a) , with 170 genes activated by Blimp-1 and 295 genes repressed by Blimp-1 (normalized average expression of ≥4 RPKM (reads per kilobase of exon model per million mapped reads) in at least one sample; false-discovery rate (FDR), ≤0.05; Supplementary Table 1 ). Cross-referencing of those differentially expressed genes with their binding of Blimp-1, as assessed by chromatin immunoprecipitation followed by deep sequencing with a biotintagged Prdm1 allele 29 in PBs generated in vitro, revealed that 28% of genes activated by Blimp-1 (47 of 170) and 41% of genes repressed by Blimp-1 (120 of 295) were bound by Blimp-1 and were thus potential direct targets of Blimp-1 (Supplementary Table 1 ). Partitioning of the proteins encoded by the differentially expressed genes into functional categories showed that the largest group of genes activated by Blimp-1 encoded proteins involved in metabolism and nutrient transporters, whereas many genes repressed by Blimp-1 encoded receptors and signaling molecules ( Fig. 2b) . This analysis also suggested a role for Blimp-1 in inhibiting B cell function, including antigen presentation (through its effect on genes encoding major histocompatibility complex class II molecules), pathogen recognition (through its effect on Tlr9) and signaling through the activating receptors (through its effect on Cd79b and Bank1). Blimp-1 also appeared to be important for the transcription of genes encoding products related to metabolic activity of the PCs, most probably related to their immunoglobulin-secreting function (through its effect on Tpst2, Syvn1 and Fkbp11). Notably, very few genes encoding products involved in the cell cycle or survival were affected by the loss of Blimp-1. For example, Myc, a known target of Blimp-1-mediated repression that encodes a central regulator of proliferation in B cells that is normally repressed in PCs 14 , was not re-expressed in Blimp-1-deficient PCs. The expression of genes encoding products essential to PC survival, such as MCL1 (encoded by Mcl1) 30 , Bim (encoded by Bcl2l11) or BCMA (encoded by Tnfrsf17) 31 , remained similarly unchanged ( Fig. 2c and data not shown).
As Blimp-1 has been linked to silencing of the B cell transcriptional program after PC differentiation 16 , we investigated whether the BM PCs reverted to the B cell stage without Blimp-1. Several B cell-associated genes, including Cd22, Spib, Cd79b and Ciita, which are usually silenced in PCs, were re-expressed in PCs in the absence of Blimp-1 ( Fig. 2c) . Most notably, Pax5 and Bcl6, which encode two of the main regulators of the B cell transcriptome and are known targets of Blimp-1 repression 13, 16 were not re-expressed in Blimp PCs ( Fig. 2c and data not shown), which demonstrated that the PCs were not reverting to the more developmentally immature B cell fate in the absence of Blimp-1. The absence of the expression of Pax5 and Bcl6 might also explain the only partial reactivation of B cell genes, such as those encoding the lectin CD22 and major histocompatibility complex class II molecules, in Blimp-1-deficient PCs, compared with their expression in wild-type B cells ( Fig. 2c,d ). Blimp-1 was also required for the normal expression of some PC genes, including the gene encoding the C-type lectin transmembrane receptor CD93 ( Fig. 2c,d) . To extend our analysis, we compared the genes activated by Blimp-1 with a published signature of 301 PC genes 6 and found that 88% of the signature genes (264 of 301) were expressed independently of Blimp-1 ( Fig. 2e) . Combined with the results of published studies [10] [11] [12] 16, 20, 29 , these results demonstrated that although Blimp-1 was essential for the establishment of the full PC gene-expression program, once formed, PCs maintained their unique transcriptome largely independently of Blimp-1.
Control of PC size and ultrastructure by Blimp-1
During our analysis of survival kinetics, we noticed that the PCs in which Blimp-1 was deleted were smaller than and had less granularity than that of Blimp-1-sufficient PCs and had a continuum of reduced expression of the PC marker CD138 and Blimp-1-GFP relative to that of Blimp-1-sufficient PCs (Fig. 3a) . Transmission electron microscopy of cellular ultrastructure also revealed that Blimp-1-deficient BM PCs had severe disruption of their distinctive dense ER (Fig. 3b) , a finding substantiated by staining with a fluorescent dye specific for the ER (Fig. 3c) . In contrast, staining for secretory granules was increased in Blimp-1-deficient PCs relative to this staining in Blimp-1-sufficient PCs (Fig. 3c) , suggestive of impaired lysosomal trafficking. As an independent measure of secretory activity of the PCs, we measured cell-surface exposure of the lysosome-associated protein CD107a. Blimp-1-deficient BM PCs had much less staining of CD107a than did their Blimp-1-sufficient counterparts ( Fig. 3c) , again indicative of impaired fusion of lysosomes with the plasma membrane. Thus, Blimp-1 was needed to maintain the characteristic PC morphology and cytoplasmic organization.
Control of immunoglobulin secretion by Blimp-1
As the fundamental function of PCs is to produce immunoglobulin, we assessed the secretory capacity of Blimp-1-sufficient and Blimp-1-deficient PCs by enzyme-linked immunospot assay. We treated Prdm1 fl/gfp Cre ERT2 and Prdm1 +/gfp Cre ERT2 mice with tamoxifen, then purified splenic and BM PCs from the mice 14-28 d later and assessed their secretion of immunoglobulin M (IgM) and all IgG. The secretion of both immunoglobulin isotypes was reduced in the spleen and, most strikingly, in the BM in the absence of Blimp-1 (Fig. 4a) . To determine if this defect resulted from a decrease in the transcription of immunoglobulin-encoding genes, we analyzed our RNA-sequencing data and found that with the notable exception of those encoding IgM and IgG3, immunoglobulin-encoding transcripts were not affected by the loss of Blimp-1 (Fig. 4b) .
The immunoglobulin heavy-chain isotypes are produced in two different isoforms that differ in their use of polyadenylation sites 32 . The longer membrane-bound receptor form has high expression in B cells, while the shorter secreted form predominates in PCs ( Supplementary  Fig. 3a) . Closer inspection of the expression of exons encoding the immunoglobulin heavy-chain constant regions revealed an increase in the expression of transcripts encoding the transmembrane form in Blimp-1-deficient PCs compared with that in Blimp-1-sufficient PCs, which thus lowered the ratio of transcripts encoding the secreted form to those encoding the membrane-specific form in Blimp-1-deficient PCs compared with that observed in Blimp-1-sufficient PCs (Fig. 4c,d) .
We then assessed protein expression by intracellular staining and flow cytometry. The proportion of PCs expressing IgG or IgA or the immunoglobulin κor λ-chain was similar in Blimp-1-deficient PCs and Blimp-1-sufficient PCs ( Fig. 4e and data not shown). In line with the reduced expression of transcripts encoding IgM in the absence of Blimp-1, the frequency of IgM + PCs was substantially diminished (Fig. 4e) . Intra-and extracellular flow cytometry staining of IgA and IgM confirmed that whereas expression of total protein was decreased in the absence of Blimp-1, expression of the membrane-specific form was maintained (Fig. 4f) . The elongation factor Ell2 has been shown to have a major role in this alternative polyadenylation process 33, 34 .
Ell2 was a direct target of Blimp-1 (Supplementary Table 1) , and its expression was reduced in Blimp-1-deficient PCs relative to that in Blimp-1-sufficient PCs (Fig. 4g) . These data suggested that Blimp-1 contributed to the efficient transition from a membrane-specific form of the immunoglobulin heavy chain to a secreted form in PCs, at least in part through direct control of Ell2 expression.
Regulation of the UPR by Blimp-1
The partial re-expression of the membrane-specific immunoglobulin heavy-chain at the expense of the secreted isoform in Blimp-1-deficient PCs could explain only in part the secretion defect observed after loss of Blimp-1. Therefore, we assessed expression of the main regulators of the UPR that control protein synthesis, folding and post-translational modifications, and expansion of the secretory apparatus ( Supplementary Fig. 3b) . Notably, expression of XBP-1, ATF4 and ATF6, the three main transcription factors known to implement this pathway 4, 35 , was significantly downregulated at the level of mRNA and protein in BM PCs after inactivation of Prdm1 ( Fig. 5a and Supplementary Table 2 ). Wes generated PBs in vitro from the progeny of mice carrying sequence encoding a biotin acceptor motif (Bio) inserted into the endogenous Prdm1 locus crossed with mice expressing the Escherichia coli biotin ligase BirA (Prdm1 Bio/Bio Rosa26 BirA/BirA mice) 29 and analyzed the cells by chromatin immunoprecipitation followed by deep sequencing; this identified Blimp-1-binding sites in Atf6 but not in Atf4 or Xbp1 (Fig. 5b and data not shown) . The regulation of Xbp1 by Blimp-1 is probably two-pronged, with Blimp-1
activating Atf6, which encodes a known inducer of Xbp1 (ref. 36) , and also promoting formation of the active spliced form of XBP-1 through the direct regulation of Ern1 (which encodes IRE1, another component of the UPR) 37 (Fig. 5b) . The requirement for Blimp-1 for the full expression of the key regulators of the UPR 'translated' into significant down-modulation of the expression of the majority of genes encoding the downstream components of the pathway (P = 0.001; Fig. 5c , Supplementary Table 2 and Supplementary Fig. 4a) . Notably, the function of Blimp-1 in the UPR was much broader than the regulation of genes encoding the key transcription factors of the UPR, as Blimp-1 directly bound to 38% of UPR genes expressed in PCs (45 of 119 genes), encoding products that represented all branches of the pathway ( Supplementary Table 2 ). Together these data demonstrated that Blimp-1 as a central transcription factor of the UPR in PCs.
To investigate the overlap between Blimp-1 and XBP-1 in controlling the UPR and the PC transcriptome more generally, we generated mice with inducible deletion of Xbp1 through use of the Cre ERT2 system (Supplementary Fig. 2d ). As reported 19, 21, 22 , inactivation of Xbp1 had no effect on the size of the PC population ( Fig. 6a) . RNA-sequencing analysis revealed that 632 genes were expressed differentially in XBP-1-deficient PCs versus XBP-1-sufficient PCs ( Fig. 6b and Supplementary Table 3 ) and, notably, Prdm1 was not down-modulated but instead was slightly upregulated in the absence of XBP-1 (with a change in expression of 1.680-fold; FDR = 0.047). The comparison of genes regulated by Blimp-1 or XBP-1 showed only a modest overlap of 56 genes (31 activated and 25 inhibited; approximately 10% of total genes regulated by either factor) ( Supplementary Fig. 4b) , which meant it was unlikely that the Blimp-1-mediated control of PC function was achieved predominantly through regulation of XBP-1, a conclusion in agreement with published studies of PCs derived in vitro 20 . Of note, XBP-1 deficiency in BM PCs resulted in a global decrease in all transcripts encoding the immunoglobulin heavy-chain complex (Igh) (Fig. 6c) . Reduced immunoglobulin expression was confirmed at the protein level (Fig. 6d) , and this correlated with reduced secretory function, as measured by expression of CD107a (Fig. 6e ) and the size of enzyme-linked immunospots for IgA and IgM (Fig. 6f and data not shown). Overall analysis of the UPR pathway revealed significant down-modulation (P = 0.0005; Fig. 6g ) similar to that observed without Blimp-1 (Fig. 5c) ; however, in contrast to the activity of Blimp-1, the activity of XBP-1 was focused on particular processes of the pathway, notably protein folding and targeting of proteins to the ER, with almost no effect on other effectors, such as the transcription factors (Supplementary Table 2 and Supplementary Fig. 4a ). Loss of XBP-1 also had very little effect on the expression of B cell and PC signature genes, beyond those encoding components of the UPR ( Supplementary  Fig. 4c ). This analysis revealed that while the functions of Blimp-1 and XBP-1 overlapped in the control of Igh expression and some aspects of the UPR, most of their functions in PCs were unique.
Requirement for Blimp-1 for full activity of the kinase mTOR
A characteristic phenotype of the Blimp-1-deficient PCs was their smaller cell size, a feature that is under the control of the mTOR ('mammalian target of rapamycin') pathway 38 . The kinase mTOR is part of two complexes, mTORC1 and mTORC2; the former regulates cell size, organelle biogenesis and protein synthesis ( Supplementary  Fig. 3c) . Analysis of the RNA-sequencing data revealed that the expression of genes encoding the core components of either complex, such as mTOR, Raptor and Rictor, was not affected by loss of Blimp-1 in PCs (data not shown). In contrast, assessment of the activity of the mTORC1 complex through analysis of the phosphorylation of mTOR itself (at Ser2448) and one of its downstream targets S6 (at Ser235 and Ser236) revealed considerable upregulation of the pathway activity in PCs, compared with its activity B cells, and that this was dependent upon Blimp-1 (Fig. 7a) . As a control, we assessed phosphorylation of the mTORC2 target Akt (at Ser473) and found this was unaffected (Fig. 7a) . The supply of amino acids, in particular of leucine, is a crucial regulator of mTORC1 activity 39 , and we determined that the expression of several carriers of amino acids was lower in Blimp-1-deficient BM PCs than in Blimp-1sufficient BM PCs (Fig. 7a,b) . The expression of one of those carriers, CD98, was particularly high on PCs and was very much dependent on Blimp-1 (Fig. 7a) . CD98 is encoded by Slc3a2 and Slc7a5, both Blimp-1-regulated genes, and the latter was also directly bound by Blimp-1 (Fig. 7b,c) . Expression of the transferrin receptor CD71 (encoded by Tfrc), another carrier known to modulate mTORC1 activity, was also decreased in absence of Blimp-1 (Fig. 7b) . Furthermore, genes encoding two members of the sestrin family 40 , Sesn1 and Sesn3, were targets of Blimp-1-mediated repression; they were bound by Blimp-1, and their expression was augmented in Blimp-1-deficient PCs (Fig. 7b,c) . Members of this family are activators of the AMP-activated protein kinase (AMPK), which inhibits mTORC1 through the phosphorylation of one of its components, Raptor 41 . In keeping with the possibility of increased AMPK activity, phosphorylation of two targets of AMPK, acetyl-CoA carboxylase (at Ser79) and Raptor (at Ser792), was significantly enhanced following loss of Blimp-1 (Fig. 7a) . These data suggested that Blimp-1 acted at multiple points to positively regulate mTORC1 activity, through activation of amino acid carriers, including CD98, and repression of the expression of the negative regulatory members of the sestrin family, and thus prevented AMPK activity. Ablation of the PC lineage at even early points after inactivation of Irf4 was in agreement with published studies of various myeloma cell lines 23 and precluded any further investigation of the downstream targets of IRF4 with these in vivo models. In contrast, we determined that mature PCs survived acute loss of either Blimp-1 or XBP-1. These findings were contrast to published studies concluding that both factors are essential for PC survival 18, 28 . The main point of difference among these studies was that the others tracked mainly the abundance and specificity of antibody as a surrogate for PC frequency 18, 28 and thus the loss of antibody production in both mutant mouse strains gave the misleading impression of the disappearance of PCs. The use of a Blimp-1-GFP reporter provided a superior tool for us to track the PCs at high resolution, compared with monitoring CD138 or immunoglobulin secretion 11 . The survival of Blimp-1-or XBP-1 deficient PCs was also compatible with published reports showing that both proteins might act as tumor suppressors in multiple myeloma 42, 43 .
Blimp-1 has long been known to be essential for the developmental transition from activated B cell to PC 12 . Blimp-1 is thought to act by repressing genes encoding the main regulators of the B cell program, including Pax5, Bcl6, Spib and Ciita, as well as silencing Myc to facilitate the post-mitotic state of mature PCs 24 . By comparison of our transcriptomic data with a published PC signature 6 , it was apparent that Blimp-1 was not needed to maintain the core identity, as defined by their transcriptional program, of already mature PCs. Blimp-1 does serve some role in repressing B cell transcription, as various B cell genes, including those encoding CD23, CD22, Spi-B, Id3 and TLR9, but not those encoding Pax-5, Bcl-6 or Myc, were reexpressed in Blimp-1-deficient PCs; this suggested that while some targets required active Blimp-1-mediated repression, the repression of others was maintained indirectly through other mechanisms in fully mature PCs. Our current findings, together with published studies [10] [11] [12] 16, 20, 29 , suggest a model in which Blimp-1 is essential for establishment of the full PC transcriptome, but once it is established, PC identity is maintained independently of Blimp-1.
Immunoglobulin-encoding transcripts account for approximately 70% of the total mRNA in long-lived PCs 6 , which allows each cell to produce close to 2 ng of antibodies per day 44 . To reach and stably maintain this secretory capacity, PCs require specialized machinery and metabolic activity. Our data demonstrated that Blimp-1 had a central role in this process through the enforcement of the UPR and mTOR pathways. In PCs, the UPR has been proposed to function not as a stress response but as a preemptive physiological pathway implemented during the early differentiation that precedes the high expression of immunoglobulins 45 . In support of that conclusion, we demonstrated that XBP-1, not Blimp-1, maintained the expression of immunoglobulin-encoding transcripts in mature PCs. Blimp-1 was intimately involved in the UPR, directly regulating Atf6 and Ern1, both of which encode products required for full XBP-1 expression and UPR function, as well as directly regulating 38% of the downstream genes of the UPR. Blimp-1 was also needed for maintenance of the characteristic cytoplasmic morphology of PCs, a function also linked to the inability to fully activate XBP-1 (refs. 21, 46) .
Beyond the UPR, the targets of Blimp-1 and XBP-1 were largely independent, suggestive of distinct functions in PC biology. The regulation of activity of the mTOR pathway by Blimp-1 represented one such unique role. mTOR has a function complementary to that of the UPR 47 , as it modulates protein synthesis or organelle biogenesis in response to environmental stimuli and, in particular, in response to nutrient availability. Moreover, enhanced mTOR activity can promote immunoglobulin production independently of XBP-1 (ref. 46) . Our data showed that Blimp-1 directly fostered this pathway through two mechanisms. Blimp-1 supported the amino acid supply of the PCs by directly promoting the expression of specific carriers, such as CD98, and prevented the activity of the inhibitory sestrin-AMPK axis. Together our studies have demonstrated that while the survival and identity of long-lived PCs is largely independent of Blimp-1, this multifunctional transcriptional regulator is essential for the molecular and cellular changes that support the extremely high and sustained rates of antibody secretion that are essential for protective immunity.
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